Image For Activity Cover
Recurrent Revascularization at 10 Years after Percutaneous Treatment of Drug-Eluting Stent Restenosis (JACC Cardiovascular Interventions January 2024)

Treatment of patients with recurrence of in-stent restenosis (ISR) remains particularly challenging, with data and guideline recommendations for repeat percutaneous coronary intervention being scant. The aim of this study was to investigate the long-term incidence of recurrent revascularization events after percutaneous treatment of drug-eluting stent (DES) ISR.


JACC: Cardiovascular Interventions Editor-in-Chief
David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC Editor
Michael C. McDaniel, MD

Tobias Koch, MD

Important Dates

Date of Release: January 8, 2024
Term of Approval/Date of CME/MOC Expiration: January 7, 2025

Availability: On-Demand
Expires on Jan 07, 2025
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By